BindingDB logo
myBDB logout

BDBM258880 US9499492, 32

SMILES: C[S@](=N)(=O)Cc1cc(Nc2ncc(F)c(n2)-c2ccc(F)cc2F)cc(c1)S(F)(F)(F)(F)F

InChI Key: InChIKey=LCUQLPMTQFAZGB-YTTGMZPUSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 258880   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cyclin-T1/Cyclin-dependent kinase 9


(Homo sapiens (Human))
BDBM258880
PNG
(US9499492, 32)
Show SMILES C[S@](=N)(=O)Cc1cc(Nc2ncc(F)c(n2)-c2ccc(F)cc2F)cc(c1)S(F)(F)(F)(F)F |r|
Show InChI InChI=1S/C18H14F8N4OS2/c1-32(27,31)9-10-4-12(7-13(5-10)33(22,23,24,25)26)29-18-28-8-16(21)17(30-18)14-3-2-11(19)6-15(14)20/h2-8,27H,9H2,1H3,(H,28,29,30)/t32-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/a8.022



Bayer Pharma Aktiengesellschaft

US Patent


Assay Description
Method 1b: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were pu...


US Patent US9499492 (2016)


BindingDB Entry DOI: 10.7270/Q2GH9GW0
More data for this
Ligand-Target Pair
Cyclin-dependent kinase 2/G1/S-specific cyclin-E1/Glutathione S-transferase P


(Homo sapiens (Human))
BDBM258880
PNG
(US9499492, 32)
Show SMILES C[S@](=N)(=O)Cc1cc(Nc2ncc(F)c(n2)-c2ccc(F)cc2F)cc(c1)S(F)(F)(F)(F)F |r|
Show InChI InChI=1S/C18H14F8N4OS2/c1-32(27,31)9-10-4-12(7-13(5-10)33(22,23,24,25)26)29-18-28-8-16(21)17(30-18)14-3-2-11(19)6-15(14)20/h2-8,27H,9H2,1H3,(H,28,29,30)/t32-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.60E+3n/an/an/an/a8.022



Bayer Pharma Aktiengesellschaft

US Patent


Assay Description
Method 2: Recombinant fusion proteins of GST and human CDK2 and of GST and human CycE, expressed in insect cells (Sf9) and purified by Glutathion-Sep...


US Patent US9499492 (2016)


BindingDB Entry DOI: 10.7270/Q2GH9GW0
More data for this
Ligand-Target Pair
Cyclin-T1/Cyclin-dependent kinase 9


(Homo sapiens (Human))
BDBM258880
PNG
(US9499492, 32)
Show SMILES C[S@](=N)(=O)Cc1cc(Nc2ncc(F)c(n2)-c2ccc(F)cc2F)cc(c1)S(F)(F)(F)(F)F |r|
Show InChI InChI=1S/C18H14F8N4OS2/c1-32(27,31)9-10-4-12(7-13(5-10)33(22,23,24,25)26)29-18-28-8-16(21)17(30-18)14-3-2-11(19)6-15(14)20/h2-8,27H,9H2,1H3,(H,28,29,30)/t32-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/a8.022



Bayer Pharma Aktiengesellschaft

US Patent


Assay Description
Method 1a: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were pu...


US Patent US9499492 (2016)


BindingDB Entry DOI: 10.7270/Q2GH9GW0
More data for this
Ligand-Target Pair